Published in Biochem Biophys Res Commun on July 31, 1992
Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A (1993) 13.27
Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol (2009) 4.52
The toxicity in vitro of beta-amyloid protein. Biochem J (1995) 2.17
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J (1994) 1.99
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A (1994) 1.94
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.77
Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A (1995) 1.60
Neuroprotective effects of curcumin. Adv Exp Med Biol (2007) 1.59
Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J (2009) 1.47
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (1995) 1.40
Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci (2004) 1.30
The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol (2006) 1.29
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol (1998) 1.29
Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol (2001) 1.25
Why pleiotropic interventions are needed for Alzheimer's disease. Mol Neurobiol (2010) 1.18
Parasporin, a human leukemic cell-recognizing parasporal protein of Bacillus thuringiensis. Clin Diagn Lab Immunol (2000) 1.15
beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci U S A (1996) 1.12
Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc Natl Acad Sci U S A (1997) 1.08
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol (2008) 1.06
Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A (1994) 1.06
Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br J Pharmacol (2004) 1.05
Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm (Vienna) (2012) 1.04
Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. Free Radic Biol Med (2008) 1.02
Oxidative stress in Parkinson's disease. Indian J Clin Biochem (2009) 0.98
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol (2013) 0.97
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. Curr Pharm Des (2008) 0.97
Estrogen-dependent transcription of the NEL-like 2 (NELL2) gene and its role in protection from cell death. J Biol Chem (2010) 0.96
Antioxidant and anti-inflammatory activities of selected medicinal plants and fungi containing phenolic and flavonoid compounds. Chin Med (2012) 0.96
Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci U S A (1998) 0.95
Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS One (2011) 0.94
Vitamin E protects against oxidative damage and learning disability after mild traumatic brain injury in rats. Neurorehabil Neural Repair (2009) 0.93
Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One (2013) 0.93
The hydrophobic environment of Met35 of Alzheimer's Abeta(1-42) is important for the neurotoxic and oxidative properties of the peptide. Neurotox Res (2002) 0.92
Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons. J Neural Transm (Vienna) (2005) 0.90
Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment. Biochem J (1998) 0.89
Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid beta protein-induced neuronal cell death. Br J Pharmacol (2001) 0.89
Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A (1996) 0.87
Back to the future with phenotypic screening. ACS Chem Neurosci (2014) 0.86
Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neurosci Lett (2009) 0.85
Neuronal death in Alzheimer's disease and therapeutic opportunities. J Cell Mol Med (2009) 0.84
Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol (2013) 0.83
Staying connected: synapses in Alzheimer disease. Am J Pathol (2004) 0.82
Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases. Cell Mol Neurobiol (2001) 0.81
Responses of Cultured Astrocytes, C6 Glioma and 1321NI Astrocytoma Cells to Amyloid beta-Peptide Fragments. Nonlinearity Biol Toxicol Med (2004) 0.80
Protective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model. Nutr Res Pract (2015) 0.79
Alpha-tocopherol decreases iron-induced hippocampal and nigral neuron loss. Cell Mol Neurobiol (2009) 0.78
The role of vitamin e in human health and some diseases. Sultan Qaboos Univ Med J (2014) 0.77
Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies? Cell Mol Neurobiol (2015) 0.77
Abeta upregulates and colocalizes with LGI3 in cultured rat astrocytes. Cell Mol Neurobiol (2007) 0.77
The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease. Front Neurosci (2017) 0.77
Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Curr Neuropharmacol (2014) 0.76
In vitro neurotoxicity of amyloid β-peptide cross-linked by transglutaminase. Cytotechnology (1997) 0.75
Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models. Korean J Physiol Pharmacol (2016) 0.75
Pre-training Catechin gavage prevents memory impairment induced by intracerebroventricular streptozotocin in rats. Neurosciences (Riyadh) (2015) 0.75
A historic study that opened a new chapter in nutritional science. Acta Pharmacol Sin (2016) 0.75
Synthesis and Biological Evaluation of Novel Multi-target-Directed Benzazepines Against Excitotoxicity. Mol Neurobiol (2016) 0.75
Lower serum uric acid levels in cerebral amyloid angiopathy: a pilot study. Neurol Sci (2014) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr (1997) 5.47
Hydrogen peroxide mediates amyloid beta protein toxicity. Cell (1994) 5.19
Clonal cell lines from the rat central nervous system. Nature (1974) 5.08
Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol (1999) 4.54
Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res (2001) 4.15
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci (2000) 4.14
Diaphragm function and alveolar hypoventilation. Q J Med (1976) 3.94
The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci (2001) 3.92
In vitro differentiation of a mouse neuroblastoma. Proc Natl Acad Sci U S A (1969) 3.80
Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology (2008) 3.54
Characterization of a unique muscle cell line. J Cell Biol (1974) 3.53
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (1987) 3.51
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
Consensus statement on the live organ donor. JAMA (2000) 3.29
Effect of community-based interventions on high-risk drinking and alcohol-related injuries. JAMA (2000) 3.24
A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal (1996) 3.18
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 3.17
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis (2003) 2.85
Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol (1998) 2.85
The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76
Induction of the proto-oncogene fos by nerve growth factor. Proc Natl Acad Sci U S A (1985) 2.74
Brain spectrin, a membrane-associated protein related in structure and function to erythrocyte spectrin. Nature (1982) 2.74
Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed (1999) 2.73
Fatal injuries to bicyclists: the experience of Dade County, Florida. J Trauma (1983) 2.73
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem (1997) 2.62
The regulation of reactive oxygen species production during programmed cell death. J Cell Biol (1998) 2.62
A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron (1997) 2.61
Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature (1988) 2.60
Fulminating vibrio parahemolyticus septicemia. A syndrome of erythemia multiforme, hemolytic anemia, and hypotension. Arch Intern Med (1974) 2.46
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke (1998) 2.35
High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother (1988) 2.30
Appearance of acetylcholine receptors during differentiation of a myogenic cell line. Proc Natl Acad Sci U S A (1972) 2.29
Changes in bone mineral content in male athletes. Mechanisms of action and intervention effects. JAMA (1996) 2.29
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis (2005) 2.21
Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging (2001) 2.20
Abnormalities of thyroid function in infants with Down syndrome. J Pediatr (1984) 2.19
Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med (2001) 2.14
Interaction of spontaneous respiration with artificial ventilation in preterm babies. J Pediatr (1983) 2.11
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Impact of anastomotic leakage on oncological outcome after rectal cancer resection. Br J Surg (2007) 2.06
Urinary diagnosis of gonorrhoea and Chlamydia in men in remote aboriginal communities. Med J Aust (1997) 2.01
Induced differentiation of a neuroblastoma. Dev Biol (1971) 2.01
Immunoglobulin biosynthesis. IV. Carbohydrate attachment to immunoglobulin subunits. J Mol Biol (1970) 2.00
Low-molecular- weight Rauscher leukemia virus protein with preferential binding for single-stranded RNA and DNA. J Virol (1976) 1.92
Visual cortical mechanisms detecting focal orientation discontinuities. Nature (1995) 1.92
Regulation of RAD54- and RAD52-lacZ gene fusions in Saccharomyces cerevisiae in response to DNA damage. Mol Cell Biol (1987) 1.90
Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell (1989) 1.89
Alterations in the surface properties of cells responsive to nerve growth factor. Nature (1978) 1.88
Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci U S A (1988) 1.87
5-bromodeoxyuridine-induced differentiation of a neuroblastoma. Proc Natl Acad Sci U S A (1970) 1.86
Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm (2003) 1.86
Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol (1988) 1.82
Cholinergic metabolism and synapse formation by a rat nerve cell line. Proc Natl Acad Sci U S A (1977) 1.81
Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet (2004) 1.80
Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg (2000) 1.79
Quantitative trait loci and candidate gene mapping of bud set and bud flush in populus. Genetics (2000) 1.76
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci (2001) 1.73
Medical audit, cancer registration, and survival in ovarian cancer. Lancet (1991) 1.73
DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci U S A (2003) 1.71
Cell-substratum adhesion in chick neural retina depends upon protein-heparan sulfate interactions. J Cell Biol (1985) 1.70
Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry (2009) 1.68
Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol (1998) 1.67
Infantile myofibromatosis: the most common fibrous tumor of infancy. J Pediatr Surg (1988) 1.67
Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg (1991) 1.66
Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol (1977) 1.65
Brain spectrin. Isolation of subunits and formation of hybrids with erythrocyte spectrin subunits. J Biol Chem (1983) 1.63
An isoform of ankyrin is localized at nodes of Ranvier in myelinated axons of central and peripheral nerves. J Cell Biol (1990) 1.63
Amino acid sequence studies on artiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo. Arch Biochem Biophys (1967) 1.60
Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol Aging (2001) 1.59
Immunoglobulin biosynthesis. 3. Blocks in defective synthesis. J Mol Biol (1968) 1.58
Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc Natl Acad Sci U S A (1991) 1.58
First symptom in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 1.58
Projection structure and oligomeric properties of a bacterial core protein translocase. EMBO J (2001) 1.57
Mouse myelomas producing precipitating antibody to nucleic acid bases and-or nitrophenyl derivatives. Nature (1968) 1.56
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer. J Clin Oncol (2002) 1.55
Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology (1998) 1.55
Nonproductive kappa immunoglobulin genes: recombinational abnormalities and other lesions affecting transcription, RNA processing, turnover, and translation. Mol Cell Biol (1985) 1.55
Oxytosis: A novel form of programmed cell death. Curr Top Med Chem (2001) 1.55
Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol (1998) 1.53
Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol (1979) 1.53
Erythrocyte ankyrin: immunoreactive analogues are associated with mitotic structures in cultured cells and with microtubules in brain. Proc Natl Acad Sci U S A (1981) 1.52
Eosinophilic granuloma of lymph nodes associated with metastatic papillary carcinoma of the thyroid. Histopathology (1992) 1.52
Family nurse practitioners in Eastern Kentucky. Med Care (1971) 1.52
Alteration of cellular adhesion by nerve growth factor. Proc Natl Acad Sci U S A (1977) 1.50
REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv (2002) 1.49
Effect of outdoor airborne particulate matter on daily death counts. Environ Health Perspect (1995) 1.49
Immunoglobulin assembly in a mouse myeloma. Proc Natl Acad Sci U S A (1968) 1.49
"Nurse": dynamic terms for a dynamic relationship. Nurs Manage (1992) 1.47
Indirect intracranial volume measurements using CT scans: clinical applications for craniosynostosis. Plast Reconstr Surg (1992) 1.46
Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem (1997) 1.46
Regulation of antioxidant metabolism by translation initiation factor 2alpha. J Cell Biol (2001) 1.44
Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis (2001) 1.44
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ (1995) 1.44
N-myristoylation is required for function of the pheromone-responsive G alpha protein of yeast: conditional activation of the pheromone response by a temperature-sensitive N-myristoyl transferase. Genes Dev (1991) 1.42
Family illness associated with Shigella infection: the interrelationship of age of the index patient and the age of household members in acquisition of illness. J Infect Dis (1981) 1.41
Dissecting x-ray-emitting gas around the center of our galaxy. Science (2013) 1.41